Skip to content

TREPP compared to Lichtenstein's technique for inguinal hernia: what's best?

Protocol for a randomised clinical trial comparing the Trans REctussheath PrePeritoneal repair (TREPP) versus Lichtenstein's technique for inguinal hernia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23859
Enrollment
1000
Registered
2016-08-08
Start date
2018-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREPP reduces the amount of patients with chronic postoperative inguinal pain (CPIP) compared with Lichtenstein's technique.

Interventions

TREPP (interventie, zie ook het artikel the nine steps of TREPP op PubMed) Lichtenstein (controle interventie)

Sponsors

Stichting Adriaan Metius Cooperatie Heelkunde Friesland Medisch Centrum Leeuwarden
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participant inclusion criteria 1. Men and women with a symptomatic primary unilateral inguinal hernia 2. Aged 18 years and over 3. ASA classification 1-3 4. Signed informed consent

Exclusion criteria

Exclusion criteria: Participant exclusion criteria 1. Previous preperitoneal operations (e.g. prostatectomy, Caesarean section) 2. Bilateral hernias 2. Recurrent hernias 3. ASA classification 4. Incarcerated hernias (acute) 5. psychiatric disease, or other reasons making follow-up or questionnaires unreliable

Design outcomes

Primary

MeasureTime frame
Chronic postoperative inguinal pain (CPIP) is measured using a visual analogue scale (VAS) in combination with the proposed modified (bedside) Quantitative sensory testing (QST) at baseline, 6 weeks, 6 months and 1 year

Secondary

MeasureTime frame
1. Health status is measured using the Short Form 36 (SF-36)and Pain Disability index and a physical examination at baseline, 6 weeks, 6 months and 1 year 2. Cost-effectiveness of the interventions is completed by calculating all direct and/or indirect costs (hospital and societal related costs) at 12 months (this means: at the end of the trial, once the last patient fulfilled the final visit)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)